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Summary Nocardia brain abscesses typically occur in immunocompromised
patients. Most cases of nocardiosis are caused by the Nocardia asteroides complex
and Nocardia brasiliensis. Here, we present a patient with a Nocardia abscessus
brain abscess. The diagnosis was conﬁrmed by DNA sequencing, and the organism
was susceptible to linezolid, clarithromycin, ceftriaxone, imipenem, tobramycin,
amikacin, minocycline and sulfamethoxazole. The patient was successfully treated
medically in combination with surgical excision.
© 2013 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier
.
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Introduction
Nocardia brain abscess is rare and accounts for
1—2% of all cerebral abscesses [1]. However, brain
abscess is the most common secondary infection
due to Nocardia. Many cases occur in immuno-
compromized patients, half of the cases have
been reported to have no identiﬁable risk fac-
tors [2]. Most cases of nocardiosis are caused by
the N. asteroides complex and N. brasiliensis. The
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http://dx.doi.org/10.1016/j.jiph.2012.11.012. asteroides complex includes N. asteroides, N.
rasiliensis, N. otitidiscaviarum, N. transvalensis,
. farcinica and N. nova [3]. N. abscessus, pre-
iously known as N. asteroides type 1, has been
ecently reported to cause disease in humans [4].
hus, N. abscessus data may be buried within this
roader designation in earlier studies. Here, we
resent a case of N. abscessus brain infection in
n immunocompetent patient.ase presentation
he patient was a 37-year-old Saudi gentleman who
as admitted with a three- to four-week history
Sciences. Published by Elsevier Ltd. All rights reserved.
Nocardia abscessus brain abscess 159
Figure 1 Magnetic resonance imaging (MRI) of the brain
showing an intra-axial, right occipital ring, enhancing
lesion surrounded by extensive vasogenic edema. There
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Figure 2 Modiﬁed Ziehl-Neelsen smear revealed acid-
f
i
u
t
p
t
i
o
t
c
w
q
t
d
r
t
f
M
M
t
p
l
h
c
8
c
H
t
s
m
w
Das a mild adjacent mass effect on the right lateral ven-
ricle with a preserved vascular ﬂow void.
f headache, which gradually increased in severity,
ssociated with some dizziness and blurred vision.
he patient did not report any fever or chills, and
e did not notice any weakness or numbness in the
xtremities. The patient was initially observed in
n outside hospital where he underwent CT and
agnetic resonance imaging (MRI), which showed a
ight occipito-parietal space-occupying lesion with
dema that was more compatible with abscess
han glioblastoma multiforme. The patient had no
istory of travel and no signiﬁcant past medical
istory. On examination, the patient was afebrile,
lert, and oriented to time, place, and person. His
ungs were clear to auscultation, and heart sounds
ere normal. His abdomen was soft and lax and had
o tenderness. He had no cranial nerve or motor
eﬁcits.
Laboratory data revealed an ESR of 10mm/h,
-reactive protein 0.5mg/dl, BUN 17mg/dl,
reatinine 0.9mg/dl, white blood cell count
5,200/microliter, and hemoglobin 14.4 g/dl. The
atient had a normal neutrophil function test,
ymphocyte count and normal immunoglobulin lev-
ls. He was negative for human immunodeﬁciency
irus.
MRI revealed an intra-axial, the right occipital,
.3 cm enhancing lesion surrounded by extensive
asogenic edema, with imaging and spectroscopic
eatures most consistent with a brain abscess
Fig. 1). There was a mild adjacent mass effect on
he right lateral ventricle, with a preserved vascu-
ar ﬂow void.
r
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tast branching ﬁlaments resembling Nocardia spp.
The patient underwent a right occipital cran-
otomy for gross total resection of the brain lesion
sing a neuronavigation system. Intra-operatively,
here was a hardened vascular capsule containing
urulent material. The lesion was resected, and
he aspirated material was sent for Gram stain-
ng. The stain revealed moderate WBCs, and no
rganism was identiﬁed. Brain tissue showed cen-
ral acute and chronic inﬂammation, with reactive
hanges consistent with an abscess. The patient
as started on intravenous vancomycin (500mg IV
6 hrs), metronidazole (500mg q8 hrs) and cef-
riaxone (2 g q12 hrs) empirically. On the following
ay, the AFB smear revealed branching ﬁlaments
esembling Nocardia spp. (Fig. 2). The organism ini-
ially grew in AFB culture, and it was then sent
or identiﬁcation to the Department of Laboratory
edicine and Pathology, Mayo Clinic, Rochester,
A, USA. Antibiotics were adjusted to include
rimethoprim-sulfamethoxazole (400mg trimetho-
rim IV q8 hrs), ceftriaxone (2 g IV q12 hrs) and
inezolid (600mg IV q12 hrs) for 5 weeks. He
ad an uneventful hospital stay, and he was dis-
harged to continue oral TMP-SMX for an additional
weeks. At the time of discharge, the ﬁnal identiﬁ-
ation and susceptibility testing became available.
e did well with no recurrence one year after
he initial presentation. Repeat MRI at that time
howed only post-operative changes and parenchy-
al encephalomalacia of the right occipital lobe
ith no recurrence.
The cultured organism was identiﬁed by
NA sequencing at the Department of Labo-
atory Medicine and Pathology, Mayo Clinic,
ochester, MA, USA. The organism was identiﬁed
s N. abscessus. Susceptibility testing revealed
hat the organism was susceptible to linezolid
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(≤0.25g/ml), clarithromycin (0.5g/ml), ceftria-
xone (8g/ml), imipenem (2g/ml), tobramycin
(≤0.25g/ml), amikacin (≤0.5g/ml), minocy-
cline (≤1g/ml) and sulfamethoxazole (≤1g/ml).
The organism was intermediately susceptible to
ciproﬂoxacin (2g/ml) and amoxicillin-clavulanic
acid (16/8g/ml).
Discussion
Nocardia spp. are aerobic gram-positive bacteria
that are ubiquitous in the environment, and infec-
tion usually occurs through inhalation or direct
cutaneous inoculation of the organism. Systemic
infection with Nocardia spp. is frequently observed
in immunocompromised hosts and is associated with
a high mortality [5]. N. abscessus was characterized
in year 2000 after a polyphasic taxonomic analysis
of four clinical isolates [6].
N. abscessus infection is thought to be rare in
humans. N. abscessus infection is the cause of
15—18% of nocardiosis cases [7—9]. In a retrospec-
tive study over 7 years (1997—2003) including 27
clinical isolates of Nocardia spp., 6 (22%) were
identiﬁed as N. abscessus [10]. Only a few cases
of N. abscessus infections have been documented
in humans: a case of pericarditis [11], four cases
of skin and soft tissue infections [12], four pul-
monary infections, and one patient with a brain
abscess [13]. Additional cases of N. abscessus brain
abscesses were reported recently and included an
HIV-positive patient with disseminated nocardio-
sis [14] and an N. abscessus brain abscess in two
immunocompetent patients [4,15]. We report an
additional case of N. abscessus brain abscess in an
immunocompetent patient.
The crude mortality rate was estimated to be
higher for N. abscessus and N. farcinica infec-
tions (78.5%, relative risk of 3.89) compared to
other nocardiosis-causing species [10]; however,
the case in the current report did well with com-
bined medical and surgical therapy. The organism
was susceptible to multiple antibiotics, including
linezolid, clarithromycin, and sulfamethoxazole.
Trimethoprim-sulfamethoxazole (TMP-SMX) is the
drug of choice in the treatment of nocardiosis
[16], and the most recent therapeutic alternative
is linezolid [17]. In one study, all N. abscessus iso-
lates were susceptible to amikacin, ceftriaxone and
linezolid [18]. In conclusion, N. abscessus brain
infection may occur in immunocompetent patients.
The combination of surgical excision and antimicro-
bial therapy seems to be associated with a good
outcome.
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